Literature DB >> 1679438

Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.

M A Pearce1, S A Howell.   

Abstract

Restriction fragment length polymorphism analysis was performed with the endonucleases EcoRI, BglII, and HinfI on a collection of Candida albicans strains comprising eight strains randomly selected from clinical microbiology laboratory specimens, three reported azole-resistant strains from treatment failures, and several subcultures of the azole-resistant strain NCPF 3310 (also known as the Darlington strain) received from different laboratories. The results demonstrated a diversity of the restriction fragment length polymorphism patterns that were obtained and revealed that two of the proposed Darlington subcultures had patterns distinct from each other and from those of the other Darlington isolates; both were also found to have lost their azole resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679438      PMCID: PMC270118          DOI: 10.1128/jcm.29.7.1364-1367.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains.

Authors:  S A Howell; A I Mallet; W C Noble
Journal:  J Appl Bacteriol       Date:  1990-11

2.  The identification of Candida albicans strains by restriction fragment length polymorphism analysis of DNA.

Authors:  R A Smith; C A Hitchcock; E G Evans; C J Lacey; D J Adams
Journal:  J Med Vet Mycol       Date:  1989

3.  Modified response to ketoconazole of Candida albicans from a treatment failure.

Authors:  D W Warnock; E M Johnson; M D Richardson; C F Vickers
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

4.  Repetitive DNA of Candida albicans: nuclear and mitochondrial components.

Authors:  J W Wills; B A Lasker; K Sirotkin; W S Riggsby
Journal:  J Bacteriol       Date:  1984-03       Impact factor: 3.490

5.  Strain differentiation of Candida albicans by morphotyping.

Authors:  S Phongpaichit; D W Mackenzie; C Fraser
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

6.  Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Med Vet Mycol       Date:  1987-10

7.  The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Gen Microbiol       Date:  1986-09

8.  Epidemiological investigation of patients with vulvovaginal candidosis. Application of a resistogram method for strain differentiation of Candida albicans.

Authors:  D W Warnock; C D Speller; J D Milne; A L Hilton; P I Kershaw
Journal:  Br J Vener Dis       Date:  1979-10

9.  Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis.

Authors:  R Matthews; J Burnie
Journal:  BMJ       Date:  1989-02-11

10.  Candida species and C. albicans biotypes in women attending clinics in genitourinary medicine.

Authors:  F C Odds; C E Webster; P G Fisk; V C Riley; P Mayuranathan; P D Simmons
Journal:  J Med Microbiol       Date:  1989-05       Impact factor: 2.472

  10 in total
  7 in total

1.  Molecular epidemiology of Candida albicans colonization and fungemia in very low birthweight infants.

Authors:  J L Robinson; A I Hartstein; R U Meuser; V H Morthland; M E Dragoon; W M Wenman
Journal:  Can J Infect Dis       Date:  1993-11

2.  Genetic analysis of azole resistance in the Darlington strain of Candida albicans.

Authors:  H Kakeya; Y Miyazaki; H Miyazaki; K Nyswaner; B Grimberg; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

4.  Colony morphotype on Sabouraud-triphenyltetrazolium agar: a simple and inexpensive method for Candida subspecies discrimination.

Authors:  G Quindós; M Fernández-Rodríguez; A Burgos; M Tellaetxe; R Cisterna; J Pontón
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

5.  Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit.

Authors:  E Bart-Delabesse; H van Deventer; W Goessens; J L Poirot; N Lioret; A van Belkum; F Dromer
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  Typing of Candida krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe.

Authors:  A Carlotti; R Grillot; A Couble; J Villard
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

Authors:  E Bart-Delabesse; P Boiron; A Carlotti; B Dupont
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.